The effects of β1-blockade on oxidative metabolism and the metabolic cost of ventricular work in patients with left ventricular dysfunction: A double-blind, placebo-controlled, positron-emission tomography study

Circulation

Volumn 102, Issue 17, 2000, Pages 2070-2075

  Beanlands, R S B ^b   Nahmias, C ^a   Gordon, E ^a   Coates, G ^a   DeKemp, R ^b   Firnau, G ^a,b   Fallen, E ^a  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^b UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Acetates; Heart failure; Metabolism

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL; PLACEBO;

ADULT; AEROBIC METABOLISM; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE METABOLISM; HUMAN; ISCHEMIC HEART DISEASE; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT OUTCOME; WHOLE BODY SCANNER;

EID: 0034711128     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.17.2070     Document Type: Article

References (35)

1. Changing strategies in the management of heart failure
2. Long-term β-blockade in dilated cardiomyopathy: Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol
3. Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: A double-blind, randomized, placebo-controlled trial
4. Usefulness of bucindolol in congestive heart failure
5. Exercise hemodynamics and myocardial metabolism during long-term beta adrenergic blockade in severe heart failure
6. Effect of β-adrenergic blockade on myocardial function and energetics in congestive heart failure
7. Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: A randomized, double-blind, placebo-controlled study
8. Clinical effects of β-adrenergic blockade in chronic heart failure: A meta-analysis of double-blind, placebo-controlled, randomized trials
9. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
10. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL: Randomised intervention trial in congestive heart failure (MERIT-HF)
11. Delineation of myocardial oxygen utilization with carbon-11-labeled acetate
12. Radiolabeled acetate as a tracer of myocardial tricarboxylic acid cycle flux
13. Regional myocardial oxygen consumption determined noninvasively in humans with [1-11C] acetate and dynamic positron emission tomography
14. An approach to ventricular efficiency by use of carbon 11-labeled acetate and positron emission tomography
15. Acute effects of dobutamine on myocardial oxygen consumption and cardiac efficiency measured using C-11 acetate kinetics in patients with dilated cardiomyopathy
16. The effects of afterload reduction on myocardial C-11 acetate kinetics and noninvasively estimated mechanical efficiency in patients with dilated cardiomyopathy
17. Myocardial efficiency during calcium sensitization with levosimendan: A noninvasive study with positron emission tomography and echocardiography in healthy volunteers
18. Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: Design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study
19. Reproducibility of left ventricular volumes by two-dimensional echocardiography
20. Quantitative assessment of mitral regurgitation by doppler color flow imaging: Angiographic and hemodynamic correlations
21. The measurement of coronary blood flow, oxygen consumption, and efficiency of the left ventricle in man
22. Assessment of patient outcome with the Minnesota living with heart failure questionnaire: Reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan
23. The 6 minute walk: A new measure of exercise capacity
24. Medical therapy can improve the biological properties of the chronically failing heart: A new era in the treatment of heart failure
25. β-Adrenergic receptor blockade in chronic heart failure
26. Potential deleterious effects of inotropic agents in the therapy of chronic heart failure
27. Cardiovascular injury induced by sympathetic catecholamines
28. Angiotensin-converting enzyme inhibition and beta-adrenoceptor blockade regress established ventricular remodeling in a canine model of discrete myocardial damage
29. The role of propranolol in the treatment of acute myocardial infarction
30. Effects of chronic β-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation
31. Predictors of improvement in left ventricular ejection fraction with carvedilol for congestive heart failure
32. Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade
33. Relationship between carbohydrate and lipid metabolism and energy balance of the heart
34. Effect of inhibition of lipolysis on myocardial oxygen consumption in the presence of isoproterenol
35. Control of the tricarboxylic acid cycle and its interaction with glycolysis during acetate utilization in the rat heart